Related Experiment Videos
Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma
K M McMasters1, T M Tuttle, S D Leach
1Division of Surgical Oncology, University of Louisville-James Graham Brown Cancer Center, Kentucky 40202, USA.
American Journal of Surgery
|December 31, 1997
Summary
Preoperative chemoradiation for extrahepatic bile duct cancer shows promise. This treatment approach appears safe, improves tumor response, and increases the rate of complete surgical resection for cholangiocarcinoma patients.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Extrahepatic bile duct cancer (cholangiocarcinoma) has a poor prognosis.
- Conventional treatments have limited success.
- Evaluating new treatment modalities is crucial.
Purpose of the Study:
- To assess the initial outcomes of preoperative chemoradiation for extrahepatic cholangiocarcinoma.
- To compare these results with historical data from conventional treatments.
- To determine the safety and efficacy of this neoadjuvant approach.
Main Methods:
- Retrospective analysis of 91 patients treated for extrahepatic cholangiocarcinoma (1983-1996).
- Comparison between patients receiving palliative care, resection, and preoperative chemoradiation followed by resection.
- Evaluation of response rates, resection margins, and complications.
Main Results:
- Preoperative chemoradiation was administered to 9 patients prior to resection.
- A 100% rate of margin-negative resection was achieved in the chemoradiation group, compared to 54% in the non-chemoradiation group.
- Pathologic complete response was observed in 3 patients, with varying histologic responses in others.
- No major intra-abdominal complications occurred in the chemoradiation group.
Conclusions:
- Preoperative chemoradiation is a safe and feasible option for extrahepatic bile duct cancer.
- This approach demonstrates significant antitumor response.
- It potentially enhances the likelihood of achieving tumor-free resection margins, warranting further investigation.